GL1X · GenesisL1 explorer

Research workbench

Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity

Analyse Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6TPF
Type
protein
Length
566 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
NTQ
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28842% helix, 20% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein27842% helix, 20% strandP23458

Ligands and binding sites

  • NTQ · (1~{S})-2,2-bis(fluoranyl)-~{N}-[4-(3-methyl-6-oxidanylidene-2,7-dihydropyrazolo[3,4-b]pyridin-4-yl) cyclohexyl]cyclopropane-1-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16050.750.8273NTQ
23860.700.8257NTQ
3580.260.7220empty

Interfaces

1 interface between chains.

  • A–B · 993 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6TPF · Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.